Company Announcements

Form 38.5a (EPT/RI) - UDG Healthcare plc

Source: RNS
RNS Number : 3160D
Deutsche Bank AG
28 June 2021
 

Ap24

 

FORM 38.5(a)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.       KEY INFORMATION

 

Name of exempt principal trader

 Deutsche Bank AG London

Company dealt in

 UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

 Ordinary Shares

Date of dealing

 25/06/2021

 

2.        DEALINGS (Note 2)

 

(a)      Purchases and sales

 

Highest price paid (Note 3)

Lowest price paid

(Note 3)

 2,152

10.5700 GBP

10.5650 GBP

 

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

 2,152

10.5674 GBP

10.5674 GBP

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3)

EUR

 

 

 

 

 

Ap25

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

3.      OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.          

               

                None

 

 

 

 

Date of disclosure

28/06/2021

Contact name

Gurpreet Kaur Kang

Telephone number

0121 407 8493

Name of offeree/offeror with which connected

 Nenelite Limited

Nature of connection (Note 6)

 Financial Adviser and Corporate Broker

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISEDZGZVLRFGMZG
image